Nephros, Inc. ( NEPH) - Key Metrics
NEPH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.55 | $0.11 | $0.06 | $0.06 |
| 2026Q1 | $0.49 | $0.01 | -$0.16 | -$0.16 |
| 2025Q4 | $0.45 | $0.01 | $0.02 | $0.02 |
| 2025Q3 | $0.45 | $0.03 | $0.01 | $0.01 |
| 2025Q2 | $0.42 | $0.02 | $0.09 | $0.09 |
NEPH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 8.11 |
| 2026Q1 | 0% | 56.87 |
| 2025Q4 | 0% | 210.34 |
| 2025Q3 | 0% | 37.19 |
| 2025Q2 | 0% | 45.65 |
NEPH Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.76% | 0% |
| 2026Q1 | -5.26% | 0% |
| 2025Q4 | 0.44% | 0% |
| 2025Q3 | 0.20% | 0% |
| 2025Q2 | 2.29% | 0% |
NEPH
Price: $3.68
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.16 USD
P/E Ratio: 27.38
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 13441
Market Capitalization: 32.8 million